Syndicates 33 and 6104 – results and estimates

Summary by AI ^BETAClose X

Hiscox Ltd has released the final results for its 2023 account for Syndicate 33, which closed with a 19.1% result against a capacity of £1,699m, exceeding the previous estimate of 12.0% to 22.0%, and Syndicate 6104's 2023 account closed with a 51.7% result against a capacity of £19m, also exceeding its previous estimate of 41.0% to 51.0%. Current estimates for Syndicate 33's 2024 account are 3.4% to 15.4% and for its 2025 account are 3.5% to 13.5%, both with a capacity of £1,699m. Syndicate 6104's 2024 estimate is 7.8% to 25.3% with a capacity of £57m, and its 2025 estimate is 23.2% to 33.2% with a capacity of £79m. Hiscox holds a 73% share in Syndicate 33 and a 0% share in Syndicate 6104.

Disclaimer*

Hiscox Ltd

03 March 2026

Syndicates 33 and 6104 - results and estimates

Hamilton, Bermuda (3 March 2026) - Hiscox Ltd (LSE: HSX), the international specialist insurer, announces the final results for Syndicate 33's and Syndicate 6104's 2023 account. It also announces the current estimates for Syndicate 33 and Syndicate 6104's 2024 and 2025 accounts.

The results for 2023 account (excluding Members' Agent fee) expressed as a percentage of capacity, are as follows:

Syndicate	Year of account	Closing result	Previous estimate	Capacity	Hiscox share
33	2023	19.1%	12.0% to 22.0%	£1,699m	73%
6104	2023	51.7%	41.0% to 51.0%	£19m	0%

The estimates for 2024 and 2025 expressed as a percentage of capacity, are as follows:

Syndicate	Year of account	Current estimate	Previous estimate	Capacity	Hiscox share
33	2024	3.4% to 15.4%	2.4% to 14.4%	£1,699m	73%
33	2025	3.5% to 13.5%	N/A	£1,699m	73%
6104	2024	7.8% to 25.3%	7.5% to 25.0%	£57m	0%
6104	2025	23.2% to 33.2%	N/A	£79m	0%

ENDS

For further information:

Hiscox Ltd

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

Media

Eleanor Orebi Gann, Chief Communications Officer, London +44 (0)20 7081 4815

Simone Selzer, Brunswick +44 (0)20 7404 5959

Notes to editors

About The Hiscox Group

1. The Syndicates' estimates are after standard personal expenses, such as Managing Agent fees and profit commission and all charges levied directly on syndicates by Lloyd's, but before Members Agents' charges.

2. Hiscox is a global specialty insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). With roots dating back to 1901, 2026 marks 125 years of Hiscox and we are proud of our long heritage in insuring specialist and complex risks. Our ambition is to continue to be among the world's most respected specialist insurers, with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle.

The Hiscox Group employs over 3,000 people in 13 countries and has customers worldwide. Through our retail businesses in the USA, UK and Europe, we offer a range of specialist insurance products in commercial and personal lines. Internationally traded, bigger-ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re.

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END